Carboplatin Alternatives Compared
| Carboplatin | Fluorouracil | Doxorubicin |
|
|---|
| Carboplatin | Fluorouracil | Doxorubicin |
|
|||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Ovarian Cancer, Cancer, Cervical Cancer. carboplatin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Anal Cancer, Breast Cancer, Cancer, Colorectal Cancer, Breast Cancer - Palliative, Cervical Cancer, Pancreatic Cancer, Stomach Cancer. fluorouracil may also be used for purposes not... View more |
Prescription only
Prescribed for Breast Cancer, Acute Myeloblastic Leukemia, Bladder Cancer, Acute Lymphoblastic Leukemia, Bronchogenic Carcinoma, Cancer, Diffuse Large B-Cell Lymphoma, Hodgkin's Lymphoma, Lymphoma... View more |
Related suggestions |
|||||||||||||||||||||||
| More about Carboplatin | More about Fluorouracil | More about Doxorubicin | ||||||||||||||||||||||||
| Generic Status | ||||||||||||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||||||||||
|
Carboplatin has an average rating of 6.3 out of 10 from a total of 4 ratings on Drugs.com. 67% of reviewers reported a positive effect, while 33% reported a negative effect. |
Fluorouracil has an average rating of 3.7 out of 10 from a total of 3 ratings on Drugs.com. 33% of reviewers reported a positive effect, while 67% reported a negative effect. |
Doxorubicin has an average rating of 6.3 out of 10 from a total of 9 ratings on Drugs.com. 57% of reviewers reported a positive effect, while 29% reported a negative effect. |
||||||||||||||||||||||||
| Drug Class | ||||||||||||||||||||||||||
| Side Effects | ||||||||||||||||||||||||||
|
Commonly reported side effects include:
See also: carboplatin side effects in more detail. |
See also: fluorouracil side effects in more detail. |
Commonly reported side effects include:
See also: doxorubicin side effects in more detail. |
||||||||||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||||||||||
View all carboplatin prices |
View all fluorouracil prices |
View all doxorubicin prices |
||||||||||||||||||||||||
| Dosage Form(s) Available | ||||||||||||||||||||||||||
|
|
|
||||||||||||||||||||||||
| Brand Names | ||||||||||||||||||||||||||
| Carboplatin Novaplus |
N/A |
N/A |
||||||||||||||||||||||||
| Half Life The half-life of a drug is the time taken for the plasma concentration of a drug to reduce to half its original value. | ||||||||||||||||||||||||||
|
120 hours |
0.33 hours |
30 hours |
||||||||||||||||||||||||
| CSA Schedule ** View glossary of terms | ||||||||||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||||||||||
| Pregnancy Category | ||||||||||||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||||||||||
| Drug Interactions | ||||||||||||||||||||||||||
|
A total of 322 drugs are known to interact with carboplatin:
|
A total of 253 drugs are known to interact with fluorouracil:
|
A total of 538 drugs are known to interact with doxorubicin:
|
||||||||||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||||||||||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||||||||||||||||||
| Disease Interactions | ||||||||||||||||||||||||||
| First Approval Date | ||||||||||||||||||||||||||
|
N/A |
N/A |
October 28, 2011 |
||||||||||||||||||||||||
| WADA Class View World Anti-Doping Agency classifications. | ||||||||||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||||||||||
| More Information | ||||||||||||||||||||||||||
| Patient resources | ||||||||||||||||||||||||||
| Professional Resources | ||||||||||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||||||||||
|
||||||||||||||||||||||||||
** The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.